Company: VRCA
Filing Date: 2025-03-11
Form Type: S-3
Source: 0001193125-25-052031
Chunk: 22

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-03-11
Form: S-3
Chunk 22
---
 debt, senior subordinated debt, subordinated debt or any combination 
 thereof, and the terms of any subordination;                                                                    |

14

| • |     | if the price (expressed as a percentage of the aggregate principal amount thereof) at which such debt securities                                                                                                                                    
 will be issued is a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof, or if applicable, the portion of the principal amount of such debt 
 securities that is convertible into another security or the method by which any such portion shall be determined;                                                                                                                                   |

| • |     | the interest rate or rates, which may be fixed or variable, or the method for determining the rate and the date                                                     
 interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates; |

| • |     | our right, if any, to defer payment of interest and the maximum length of any such deferral period; |

| • |     | if applicable, the date or dates after which, or the period or periods during which, and the price or prices at                                                                
 which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions; |

| • |     | the date or dates, if any, on which, and the price or prices at which we are obligated, pursuant to any mandatory                                                                                                   
 sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder’s option to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable; |

| • |     | the denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and 
 any integral multiple thereof;                                                                                    |

| • |     | any and all terms, if applicable, relating to any auction or remarketing of the debt securities of that series                                                                           
 and any security for our obligations with respect to such debt securities and any other terms which may be advisable in connection with the marketing of debt securities of that series; |

| • |     | whether the debt securities of the series shall be issued in whole or in part in the form of a global security or 
 securities;                                                                                                       |

| • |     | the terms and conditions, if any, upon which such global security or securities may be exchanged in whole or in 
 part